BioMarin to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, August 3, at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will host a conference call and webcast on August 3, 2022, at 4:30 p.m. ET to discuss its second quarter 2022 financial results and provide a business update. The call can be accessed via U.S. and international dial-in numbers, with a replay available for one week following the event. BioMarin specializes in developing therapies for serious rare diseases, with a portfolio of seven commercial products and multiple candidates in various stages of development.

Positive

• BioMarin is focused on rare disease therapies, indicating a strong niche market.
• The upcoming financial results call suggests transparency and engagement with investors.

Negative

• None.

SAN RAFAEL, Calif., July 20, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, August 3^rd, at 4:30 p.m. ET to discuss second quarter 2022 financial results and provide a general business update.

BioMarin to Host Second Quarter 2022 Financial Results on Wednesday, August 3 at 4:30pm ET

Dial-in Number 
U.S. / Canada Dial-in Number: (800) 231-0316
International Dial-in Number: +1 (314) 696-0504

U.S. / Canada Replay Dial-in Number: (800) 645-7964
International Replay Dial-in Number: (757) 849-6722
Playback ID: 2361#

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company's portfolio consists of seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-wednesday-august-3-at-430pm-et-301590347.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin's second quarter 2022 financial results call?

The financial results call is scheduled for August 3, 2022, at 4:30 p.m. ET.

How can I access the BioMarin conference call on August 3?

You can access the call via U.S. dial-in number (800) 231-0316 or international dial-in number +1 (314) 696-0504.

What does BioMarin specialize in?

BioMarin specializes in developing therapies for serious and life-threatening rare diseases.

What products does BioMarin have?

BioMarin has a portfolio of seven commercial products and multiple clinical and preclinical candidates.